Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Gyeong | - |
dc.contributor.author | Kang, Hyok Jo | - |
dc.contributor.author | Lim, Myong Cheol | - |
dc.contributor.author | Park, Bo young | - |
dc.contributor.author | Park, Soo Jin | - |
dc.contributor.author | Jung, So-Youn | - |
dc.contributor.author | Lee, Seeyoun | - |
dc.contributor.author | Kang, Han-Sung | - |
dc.contributor.author | Kong, Sun-Young | - |
dc.contributor.author | Lee, Eun Sook | - |
dc.date.accessioned | 2022-07-10T14:51:37Z | - |
dc.date.available | 2022-07-10T14:51:37Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1598-2998 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/148440 | - |
dc.description.abstract | Purpose The purpose of this study was to investigate decision patterns to reduce the risks of BRCA- related breast and gynecologic cancers in carriers of BRCA pathogenic variants. We found a change in risk-reducing (RR) management patterns after December 2012, when the National Hearth Insurance System (NHIS) of Korea began to pay for BRCA testing and risk-reducing salpingo-oophorectomy (RRSO) in pathogenic-variant carriers. Materials and Methods The study group consisted of 992 patients, including 705 with breast cancer (BC), 23 with ovarian cancer (OC), 10 with both, and 254 relatives of high-risk patients who underwent BRCA testing at the National Cancer Center of Korea from January 2008 to December 2016.We analyzed patterns of and factors in RR management. Results Of the 992 patients, 220 (22.2%) were carriers of BRCA pathogenic variants. About 92.3% (203/220) had a family history of BC and/or OC, which significantly differed between BRCA1 and BRCA2 carriers (p ˂ 0.001). All 41 male carriers chose surveillance. Of the 179 female carriers, 59 of the 83 carriers (71.1%) with BC and the 39 of 79 unaffected carriers (49.4%) underwent RR management. None of the carriers affected with OC underwent RR management. Of the management types, RRSO had the highest rate (42.5%) of patient choice. The rate of RR surgery was significantly higher after 2013 than before 2013 (46.3% [74/160] vs. 31.6% [6/19], p ˂ 0.001). Conclusion RRSO was the preferred management for carriers of BRCA pathogenic variants. The most important factors in treatment choice were NHIS reimbursement and/or the severity of illness. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한암학회 | - |
dc.title | Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Bo young | - |
dc.identifier.doi | 10.4143/crt.2018.079 | - |
dc.identifier.scopusid | 2-s2.0-85059916894 | - |
dc.identifier.wosid | 000455439600027 | - |
dc.identifier.bibliographicCitation | Cancer Research and Treatment, v.51, no.1, pp.280 - 288 | - |
dc.relation.isPartOf | Cancer Research and Treatment | - |
dc.citation.title | Cancer Research and Treatment | - |
dc.citation.volume | 51 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 280 | - |
dc.citation.endPage | 288 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.identifier.kciid | ART002430582 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.subject.keywordAuthor | BRCA1 | - |
dc.subject.keywordAuthor | BRCA2 | - |
dc.subject.keywordAuthor | Familial breast cancer | - |
dc.subject.keywordAuthor | Ovarian neoplasms | - |
dc.subject.keywordAuthor | Prophylactic surgical procedure | - |
dc.identifier.url | https://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.079 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.